BIOMAT Database Logo BIOMAT Database Logo

Phase II clinical trial of ftorafur in 5-fluorouracil-refractory colorectal cancer. 1977

T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracil.
March 1997, Anti-cancer drugs,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
May 1978, Cancer treatment reports,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer.
May 2007, Clinical colorectal cancer,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
March 1978, Cancer treatment reports,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
April 1978, Cancer treatment reports,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
A Phase II Study of Oxaliplatin Combined with 5-Fluorouracil and Leucovorin (Mayo Clinic Regimen) in 5-Fluorouracil Refractory Colorectal Cancer.
June 2002, Cancer research and treatment,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
Irinotecan in 5-fluorouracil-refractory colorectal cancer.
August 2002, Clinical colorectal cancer,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer.
December 2016, Clinical colorectal cancer,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.
January 2011, Cancer chemotherapy and pharmacology,
T Buroker, and A Miller, and L Baker, and M McKenzie, and M Samson, and V K Vaitkevicius
[Phase II clinical trial of oxaliplatin alone for refractory advanced colorectal cancer].
August 2003, Ai zheng = Aizheng = Chinese journal of cancer,
Copied contents to your clipboard!